Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 24, 2022 11:00 ET | Source: Precipio, Inc.

Sharon Robins Joins Precipio’s Products Division as Senior Director of Laboratory & Hospital Sales

NEW HAVEN, Conn., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), welcomes Sharon Robins as the Company’s Senior Director of Laboratory &...
August 16, 2022 11:00 ET | Source: Precipio, Inc.

Precipio Launches New 1-Step Technology for all HemeScreen Assays

NEW HAVEN, Conn., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces the launch of its second generation of HemeScreen panels. Precipio’s...
August 10, 2022 10:00 ET | Source: Precipio, Inc.

Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development

NEW HAVEN, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), welcomes Toni-Ann Mills as the Company’s Senior Director for Learning &...
August 08, 2022 10:00 ET | Source: Precipio, Inc.

Precipio Announces Second Quarter Shareholder Update Call

NEW HAVEN, Conn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2022 shareholder update call on Monday, August 15th at...
July 20, 2022 10:30 ET | Source: Precipio, Inc.

Precipio to distribute HemeScreen® through Fisher Healthcare channel

NEW HAVEN, Conn., July 20, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has entered into an agreement with Fisher Healthcare,...
June 14, 2022 14:00 ET | Source: Precipio, Inc.

Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote

NEW HAVEN, Conn., June 14, 2022 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that the Company’s 2022 Annual Meeting of Stockholders was adjourned...
June 13, 2022 11:00 ET | Source: Precipio, Inc.

Keith Meadors Joins Precipio to Lead its Products Division

NEW HAVEN, Conn., June 13, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company, Precipio, Inc. (NASDAQ: PRPO), today announced that Keith Meadors has joined Precipio as its Senior Vice...
May 24, 2022 10:30 ET | Source: Precipio, Inc.

Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in Europe

NEW HAVEN, Conn., May 24, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company, Precipio, Inc. (NASDAQ: PRPO), today announced that it has received CE-IVD approval for sale of its...
May 10, 2022 10:30 ET | Source: Precipio, Inc.

Precipio Signs First IV-Cell Customer Agreement

NEW HAVEN, Conn., May 10, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that American Oncology Network (AON) of Fort Myers, Florida,...
April 26, 2022 10:00 ET | Source: Precipio, Inc.

Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference

NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to announce its participation and the presentation of HemeScreen,...